NRAS Q61K
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors (NCT07584226) | Relay Therapeutics, Inc. | 2026-03-09 |
Track NRAS Q61K automatically
Every clearance here is in the API, with alerts when new ones post.